Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   ARCHIVES OF IRANIAN MEDICINE   April 2019 , Volume 22 , Number 4; Page(s) 204 To 210.
 
Paper: 

Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention (Review Article)

 
 
Author(s):  SARRAFZADEGAN NIZAL, MOHAMMADIFARD NOUSHIN*
 
* Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
 
Abstract: 
Four decades ago, Iran encountered rapid sociodemographic and economic transitions. This review was carried out to investigate the trend of cardiovascular disease (CVD) prevalence, mortality and morbidity, relevant challenges and suggestions for prevention of CVD. In Iran, the most prevalent causes of death have transited from infectious and diarrheal diseases in 1960 to CVD few decades ago. CVD was the first leading cause of mortality and a million disability adjusted life years (DALYs) led to 46% of all deaths and 20%-23% of the burden of disease in Iran. Ischemic heart disease and stroke are considered the first and second cause of death and DALYs in Iran, respectively. CVD rising epidemic might be related to socioeconomic and cultural changes, nutrition transition, inadequate physical activity, industrialization and urbanization and increasing life expectancy, increasing metabolic and physical risk factors, low accessibility and affordability to primary care and treatment, and low compliance because of economic and psychological problems. Thus, planning and implementing strategies for prevention and control of the disease and its risk factors are on top of the ministry of health agenda in the recent years. Health promotion strategies to prevent and control CVD risk factors, early detection of the disease and treatment of acute and chronic CVD events are essential elements for reducing the burden of CVD in Iran.
 
Keyword(s): Cardiovascular disease,Ischemic heart disease,Prevention,Risk factor,Stroke
 
 
References: 
 
Click to Cite.
APA: Copy

SARRAFZADEGAN, N., & MOHAMMADIFARD, N. (2019). Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention (Review Article). ARCHIVES OF IRANIAN MEDICINE, 22(4), 204-210. https://www.sid.ir/en/journal/ViewPaper.aspx?id=665188



Vancouver: Copy

SARRAFZADEGAN NIZAL, MOHAMMADIFARD NOUSHIN. Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention (Review Article). ARCHIVES OF IRANIAN MEDICINE. 2019 [cited 2021May13];22(4):204-210. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=665188



IEEE: Copy

SARRAFZADEGAN, N., MOHAMMADIFARD, N., 2019. Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention (Review Article). ARCHIVES OF IRANIAN MEDICINE, [online] 22(4), pp.204-210. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=665188.



 
  pdf-File
Yearly Visit 202
 
Latest on Blog
Enter SID Blog